Loss of STAT6 leads to anchorage-independent growth and trastuzumab resistance in HER2+ breast cancer cells
2020 · PLoS ONE · 8 citations
https://doi.org/10.1371/journal.pone.0234146
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Molly DiScala is an academic researcher.
Click to start Chat